Skip to main content
LGVN
NASDAQ Life Sciences

Longeveron Finalizes Resale of 30.8M Shares, Enabling Massive Dilution from Deeply Discounted Private Placement

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$1.13
Mkt Cap
$25.595M
52W Low
$0.475
52W High
$1.83
Market data snapshot near publication time

summarizeSummary

This 424B3 filing finalizes the registration for resale of 30.8 million shares by selling stockholders, making these shares immediately available for sale on the open market. This follows the S-1 registration filed on April 10, 2026, and operationalizes the significant dilution previously disclosed. The shares originate from a private placement at a deeply discounted price of $0.52 per share (compared to the current stock price of $1.13), as well as convertible preferred stock and placement agent warrants. The potential issuance and sale of these shares represent a massive potential dilution of over 140% relative to current outstanding Class A common stock. This event introduces substantial selling pressure on the stock, especially for a company already facing "substantial doubt about its ability to continue as a going concern" and Nasdaq delisting risks due to its low share price. The company will not receive any proceeds from these sales, except for a minor amount if placement agent warrants are exercised for cash. Investors should anticipate significant downward pressure on the stock price as these shares become available for disposition.


check_boxKey Events

  • Finalizes Resale of 30.8M Shares

    This prospectus enables selling stockholders to dispose of 30,865,385 shares of Class A common stock, formalizing the offering registered in the S-1 on April 10, 2026.

  • Massive Potential Dilution

    The shares available for resale represent over 140% potential dilution to the current Class A common stock outstanding, creating significant selling pressure.

  • No Proceeds to Company

    Longeveron will not receive any proceeds from the sale of these shares by the selling stockholders, except for a minor amount (up to $1.3M) from potential warrant exercises.

  • Origin from Deeply Discounted Private Placement

    The shares were primarily issued in a private placement at $0.52 per share, significantly below the current market price of $1.13.


auto_awesomeAnalysis

This 424B3 filing finalizes the registration for resale of 30.8 million shares by selling stockholders, making these shares immediately available for sale on the open market. This follows the S-1 registration filed on April 10, 2026, and operationalizes the significant dilution previously disclosed. The shares originate from a private placement at a deeply discounted price of $0.52 per share (compared to the current stock price of $1.13), as well as convertible preferred stock and placement agent warrants. The potential issuance and sale of these shares represent a massive potential dilution of over 140% relative to current outstanding Class A common stock. This event introduces substantial selling pressure on the stock, especially for a company already facing "substantial doubt about its ability to continue as a going concern" and Nasdaq delisting risks due to its low share price. The company will not receive any proceeds from these sales, except for a minor amount if placement agent warrants are exercised for cash. Investors should anticipate significant downward pressure on the stock price as these shares become available for disposition.

この提出時点で、LGVNは$1.13で取引されており、市場はNASDAQ、セクターはLife Sciences、時価総額は約$2559.5万でした。 52週の取引レンジは$0.48から$1.83でした。 この提出書類はネガティブの市場センチメント、重要度スコア9/10と評価されました。

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed LGVN - Latest Insights

LGVN
Apr 17, 2026, 4:23 PM EDT
Filing Type: 424B3
Importance Score:
9
LGVN
Apr 10, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
8
LGVN
Apr 10, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
LGVN
Apr 10, 2026, 4:01 PM EDT
Filing Type: S-1
Importance Score:
9
LGVN
Mar 25, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
LGVN
Mar 17, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
LGVN
Mar 17, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
9
LGVN
Mar 12, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
LGVN
Mar 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
LGVN
Mar 11, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8